DNA synthesizers are laboratory instruments that are used to chemically synthesize strands of deoxyribonucleic acid (DNA) by combining nucleotide bases. DNA synthesizers automate the chemical synthesis process by sequentially adding activated nucleotides to a growing DNA chain. This helps produce DNA fragments in a more rapid, reliable, and cost-effective manner as compared to traditional cloning and isolation from organisms. These instruments are commonly used in genetic engineering and molecular biology research for various applications such as DNA sequencing, synthesis of oligonucleotides, site-directed mutagenesis, and gene synthesis. The global demand for DNA synthesizers has increased significantly owing to the growing applications of synthetic biology, expansion of genomics and proteomics research, and investments in genomics-driven drug discovery programs by pharmaceutical companies.

The global DNA Synthesizer Market is estimated to be valued at US$ 4.03 Billion in 2024 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/dna-synthesizer-market-5913

Market key trends:

The DNA synthesizer market is witnessing increased demand for high-throughput and faster DNA synthesis instruments. Key players in the market are focusing on developing next-generation technologies to automate multistep DNA assembly and accelerate large-scale DNA synthesis. For instance, companies are developing benchtop workstations and modular DNA assembly tools that can synthesize multiple, kilobase-scale DNA molecules in parallel at a more rapid pace. Additionally, the growing adoption of cloud-based automated DNA synthesis services by biotech and pharma companies is expected to propel market growth over the forecast period. By outsourcing their DNA synthesis needs to cloud-based providers, researchers can accelerate the development of new applications and reduce costs associated with capital equipment investment and operating internal DNA synthesis capability.

Porter’s Analysis

Threat of new entrants: The DNA Synthesizer market requires huge capital investment for R&D which makes it difficult for new players to enter this market.

Bargaining power of buyers: Buyers have moderate bargaining power as there are number of established players providing DNA synthesizers.

Bargaining power of suppliers: Major suppliers in this market include companies providing oligonucleotides and reagents. Their bargaining power is moderate due to presence of substitutes.

Threat of new substitutes: Threat of substitute is moderate as some techniques like gene assembly can be used as alternative for DNA synthesis.

Competitive rivalry: The market is consolidated with big players competing on the basis of product quality, reliability and pricing.

Key Takeaways

The global DNA Synthesizer market is expected to witness high growth.
Regional analysis: The North America region dominates the global DNA Synthesizer market due to presence of major players and rising R&D expenditure. Asia Pacific is expected to be the fastest growing region over the forecast period owing to increasing investments by regional governments towards synthetic biology.

Key players operating in the DNA Synthesizer market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, DNA Script, Ribbon Biolabs GmbH, and Camena Bioscience.